Potential vaccine candidates across the world are in the race to become a reality against the highly-infectious coronavirus which has claimed innumerable lives around the globe so far. Recently, Pfizer and Modern released the results of clinical trials of their respective experimental coronavirus vaccines. Both the candidates have reportedly shown an efficacy rate of over 90 per cent. Meanwhile, the first batch of Russia’s Sputnik V vaccine for COVID-19 is expected to reach Kanpur’s Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine’s Phase 2 and Phase 3 human clinical trials will be conducted. The decision was taken after Dr Reddy Laboratories got approval from the Drugs Controller General of India (DCGI).
Israel closed its schools on Thursday, a day before entering a second national coronavirus lockdown, as daily infections topped 4,500.
This was the first indication that the US trial will remain on hold until the US Food and Drug Administration and a safety panel investigate the case.
Afghanistans dwindling community of Sikhs and Hindus is shrinking to its lowest levels. With growing threats from the local Islamic State affiliate, many are choosing to leave the country of their birth to escape the insecurity and a oncethriving community of as many as 250,000 members now counts fewer than 700.